Export

EN
FR
Ritonavir
Essential medicine status
General description
Ritonavir is recommended for use in combination with other protease inhibitors as a pharmacological booster in the prevention and treatment of HIV/AIDS, and not as an antiretroviral in its own right.
INN
Ritonavir
ATC codes
J05AE03
Medicine type
Chemical agent
EML status history
Wikipedia
Ritonavir
DrugBank
Ritonavir
Recommendations
Section
Antiretrovirals > Protease inhibitors
  • Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable)
Indications
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified